Svas Biosana SpA (MIL:SVS) ROCE % : 10.74% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Svas Biosana SpA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Svas Biosana SpA's annualized ROCE % for the quarter that ended in Jun. 2023 was 10.74%.

Svas Biosana SpA ROCE % Historical Data

The historical data trend for Svas Biosana SpA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Svas Biosana SpA ROCE % Chart

Svas Biosana SpA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

10.01

8.42

8.10

7.43

30.96

Svas Biosana SpA Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial					6.63	9.53	9.99	10.74	27.69

Svas Biosana SpA ROCE % Calculation

Svas Biosana SpA's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	6.521	/	( ( (135.886 - 49.54)	+	(146.229 - 57.161) )	/ 2 )
	=	6.521	/	( (86.346	+	89.068)	/ 2 )
	=	6.521	/	87.707
	=	7.43 %

Svas Biosana SpA's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	9.538	/	( ( (146.229 - 57.161)	+	(148.16 - 59.565) )	/ 2 )
	=	9.538	/	( ( 89.068	+	88.595 )	/ 2 )
	=	9.538	/	88.8315
	=	10.74 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

Svas Biosana SpA (MIL:SVS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Svas Biosana SpA ROCE % Related Terms

Thank you for viewing the detailed overview of Svas Biosana SpA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Svas Biosana SpA (MIL:SVS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Svas Biosana SpA (MIL:SVS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Via Trentola, 7, Somma Vesuviana, ITA

Website

https://www.svas.it

Svas Biosana SpA operates in the production and distribution of medical device.

Svas Biosana SpA (MIL:SVS) Headlines

No Headlines